AMBER LENSES TO BLOCK BLUE LIGHT AND IMPROVE SLEEP: A RANDOMIZED TRIAL

REFERENCES

• Barbini B, Benedetti F, Colombo C, Dotoli D, Bernasconi A, Cigala-Fulgosi M, Florita M, Smeraldi E. (2005). Dark therapy for mania: A pilot study. Bipolar Disord. 7:98–101.
   PubMed Web of Science ®Google Scholar
• Barron ML. (2007). Light exposure, melatonin secretion, and menstrual cycle parameters: An integrative review. Biol. Res. Nurs. 9:49–69.
   PubMed Web of Science ®Google Scholar
• Bauer M, Glenn T, Whybrow PC, Grof P, Rasgon N, Alda M, Marsh W, Sagduyu K, Schmid R, Adli M. (2008). Changes in self-reported sleep duration predict mood changes in bipolar disorder. Psychol. Med. 38:1069–1071.
   PubMedGoogle Scholar
• Benedetti F, Dallaspezia S, Fulgosi MC, Colombo BBC, Smeraldi E. (2007). Phase advance is an actimetric correlate of antidepressant response to sleep deprivation and light therapy in bipolar depression. Chronobiol. Int. 24:921–937.
   PubMed Web of Science ®Google Scholar
• Blask DE. (2009). Melatonin, sleep disturbance and cancer risk. Sleep Med. Rev. 13:257–264.
   PubMed Web of Science ®Google Scholar
• Brainard GC, Hanifin JP, Greeson JM, Byrne B, Glickman G, Gerner E, Rollag MD. (2001). Action spectrum for melatonin regulation in humans: Evidence for a novel circadian photoreceptor. J. Neurosci. 21:6405–6412.
   PubMed Web of Science ®Google Scholar
• Casale TB, Blaiss MS, Gelfand E, Gilmore T, Harvey PD, Hindmarch I, Simons FE, Spangler DL, Szefler SJ, Terndrup TE, Waldman SA, Weiler J, Wong DF. (2003). Antihistamine Impairment Roundtable. First do no harm: Managing antihistamine impairment in patients with allergic rhinitis. J. Allergy Clin. Immunol. 111:S835–S842.
   Google Scholar
• Dacey DM, Liao HW, Peterson BB, Robinson FR, Smith VC, Pokorny J, Yau KW, Gamlin PD. (2005). Melanopsin-expressing ganglion cells in primate retina signal colour and irradiance and project to the LGN. Nature 433:749–754.
   PubMed Web of Science ®Google Scholar
• Edinger JD, Wohlgemuth WK, Radtke RA, Coffman CJ, Carney CE. (2007). Dose-response effects of cognitive-behavioral insomnia therapy: A randomized clinical trial. Sleep 30:203–212.
   PubMed Web of Science ®Google Scholar
• Gooley JJ, Lu J, Fischer D, Saper CB. (2003). A broad role for melanopsin in nonvisual photoreception. J. Neurosci. 23:7093–7106.
   PubMed Web of Science ®Google Scholar
• Hallam K, Norman T, Olver J, Begg D. (2009). Abnormal dose-response melatonin suppression by light in Bipolar Type I patients compared with healthy adult subjects. Acta Neuropsychiatrica 21:246–255.
   PubMedGoogle Scholar
• Hanifin JP, Stewart KT, Smith P, Tanner R, Rollag M, Brainard GC. (2006). High-intensity red light suppresses melatonin. Chronobiol. Int. 23:251–268.
   PubMed Web of Science ®Google Scholar
• Johnson EO, Roehrs T, Roth T, Breslau N. (1998). Epidemiology of alcohol and medication as aids to sleep in early adulthood. Sleep 21:178–186.
   PubMed Web of Science ®Google Scholar
• Kayumov L, Casper RF, Hawa RJ, Perelman B, Chung SA, Sokalsky S, Shapiro CM. (2005). Blocking low-wavelength light prevents nocturnal melatonin suppression with no adverse effect on performance during simulated shift work. J. Clin. Endocrinol. Metab. 90:2755–2761.
   PubMed Web of Science ®Google Scholar
• Lewy AJ, Lefler BJ, Emens JS, Bauer VK. (2006). The circadian basis of winter depression. Proc. Natl. Acad. Sci. USA 103:7414–7419.
   PubMed Web of Science ®Google Scholar
• Lockley SW. (2007). Safety considerations for the use of blue-light blocking glasses in shift-workers. J. Pineal Res. 42:210–211.
   PubMed Web of Science ®Google Scholar
• Lockley SW, Brainard GC, Czeisler CA. (2003). High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light. J. Clin. Endocrinol. Metab. 88:4502–4505.
   PubMed Web of Science ®Google Scholar
• Mahoney D. (2004). Red contact lenses help relieve acute migraine. Fam. Pract. News 34:59.
   Google Scholar
• Mai E, Buysse DJ. (2008). Insomnia: Prevalence, impact, pathogenesis, differential diagnosis, and evaluation. Sleep Med. Clin. 3:167–174.
   PubMedGoogle Scholar
• Perlis ML, Smith MT. (2008). How can we make CBT-I and other BSM services widely available? J. Clin. Sleep Med. 4:11–13.
   PubMed Web of Science ®Google Scholar
• Phelps J. (2008a). Bipolar disorder, light, and darkness: Treatment implications. Available at: http://www.psycheducation.org/depression/LightDark.htm#UVEX (accessed December 28, 2008).
   Google Scholar
• Phelps J. (2008b). Dark therapy for bipolar disorder using amber lenses for blue light blockade. Med. Hypotheses 70:224–229.
   PubMed Web of Science ®Google Scholar
• Plante DT, Winkelman JW. (2008). Sleep disturbance in bipolar disorder: Therapeutic implications. Am. J. Psychiatry 165:830–843.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Touitou Y, Smolensky MH. (2008). Ethical and methodological standards for laboratory and medical biological rhythm research. Chronobiol. Int. 25:999–1016.
   PubMed Web of Science ®Google Scholar
• Revell VL, Skene DJ. (2007). Light-induced melatonin suppression in humans with polychromatic and monochromatic light. Chronobiol. Int. 24:1125–1137.
   PubMed Web of Science ®Google Scholar
• Rosenberg RP. (2006). Sleep maintenance insomnia: Strengths and weaknesses of current pharmacologic therapies. Ann. Clin. Psychiatry 18:49–56.
   PubMedGoogle Scholar
• Sample PA, Esterson FD, Weinreb RN, Boynton RM. (1988). The aging lens: In vivo assessment of light absorption in 84 human eyes. Invest. Ophthalmol. Vis. Sci. 29:1306–1311.
   PubMed Web of Science ®Google Scholar
• Sasseville A, Paquet N, Sévigny J, Hébert M. (2006). Blue blocker glasses impede the capacity of bright light to suppress melatonin production. J. Pineal Res. 41:73–78.
   PubMed Web of Science ®Google Scholar
• Thapan K, Arendt J, Skene DJ. (2001). An action spectrum for melatonin suppression: Evidence for a novel non-rod, non-cone photoreceptor system in humans. J. Physiol. 535:261–267.
   PubMed Web of Science ®Google Scholar
• Watson D, Clark LA, Tellegen A. (1988). Development and validation of brief measures of positive and negative affect: The PANAS scale. J. Pers. Soc. Psychol. 54:1063–1070.
   PubMed Web of Science ®Google Scholar
• Wehr TA, Turner EH, Shimada JM, Lowe CH, Barker C, Leibenluft E. (1998). Treatment of rapidly cycling bipolar patient by using extended bed rest and darkness to stabilize the timing and duration of sleep. Biol. Psychiatry 43:822–828.
   PubMed Web of Science ®Google Scholar
• Weissman MM, Sholomskas D, Pottenger D, Prusoff BA, Locke BZ (1977). Assessing depressive symptoms in five psychiatric populations: A validation study. Am J Epidemiol. 106:203–214.
   PubMed Web of Science ®Google Scholar
• Wirz-Justice A. (2009). From the basic neuroscience of circadian clock function to light therapy for depression: On the emergence of chronotherapeutics. J. Affect. Disord. 116:159–160.
   PubMed Web of Science ®Google Scholar
• Wirz-Justice A, Quinto C, Cajochen C, Werth E, Hock C. (1999). A rapid-cycling bipolar patient treated with long nights, bedrest, and light. Biol. Psychiatry 45:1075–1077.
   PubMed Web of Science ®Google Scholar